Academic Journal
Q1Journal of Atherosclerosis and Thrombosis
About Journal of Atherosclerosis and Thrombosis
About Journal of Atherosclerosis and Thrombosis
Journal of Atherosclerosis and Thrombosis is a peer-reviewed scholarly journal published by Japan Atherosclerosis Society (Japan). It focuses on Q1. Publication coverage spans 1994-1998, 2000-2026.
Key indicators: ISSN 1880-3873, 1340-3478; H-index 95.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (95): Strong citation impact — 95 articles cited at least 95 times each, reflecting solid influence.
Publishing in Journal of Atherosclerosis and Thrombosis
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Atherosclerosis and Thrombosis?
1880-3873, 1340-3478.
Who publishes Journal of Atherosclerosis and Thrombosis?
Japan Atherosclerosis Society.
What are Journal of Atherosclerosis and Thrombosis's metrics?
H-index 95.
Is Journal of Atherosclerosis and Thrombosis peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Lipoproteins and Cardiovascular Health; Diabetes, Cardiovascular Risks, and Lipoproteins; Cardiovascular Health and Disease Prevention; Adipokines, Inflammation, and Metabolic Diseases; Cerebrovascular and Carotid Artery Diseases; Peripheral Artery Disease Management.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
The Impact of Ambient Temperature on the Cardiovascular and Cerebrovascular Disease Incidence during 2009-2023 in Zhanjiang, Guangdong, China
Shanshan Fan, Jilin Wang, Mingyi Tang, Juncheng Liu et al.
2026-10-01 · DOI: 10.5551/jat.66035Blood Lipid Levels and Intraocular Pressure in a Japanese Population: the JPHC-NEXT Eye Study
Maho Sato, Akiko Hanyuda, Kazumasa Yamagishi, Kenya Yuki et al.
2026-10-01 · DOI: 10.5551/jat.66081Beyond Sinus Rhythm: Rhythm Control and Mechanism-Based Secondary Prevention in Atrial Fibrillation–Related Stroke
Yasuhiro Nishiyama
2026-10-01 · DOI: 10.5551/jat.rv22055Serum ADAMTS18 Levels at Admission Are Associated With 3-Month Functional Outcome After Acute Ischemic Stroke
Ting Cui, Huan Wang, Yuyi Zhu, Mingxi Chen et al.
2026-10-01 · DOI: 10.5551/jat.66202Diet and Atherosclerosis Prevention: Rethinking the Significance of “The Japan Diet”
Chizuko Maruyama
2026-10-01 · DOI: 10.5551/jat.rv22057ATP Inside and Out: Understanding Atherosclerosis Through Energy Metabolism and Purinergic Signaling
Osamu Baba, Koh Ono
2026-10-01 · DOI: 10.5551/jat.rv22054Liver Dysfunction Assessed by Albumin – Bilirubin (ALBI) Score is Associated with Disturbed Cholesterol Profiles and Reduced Survival in Patients with Chronic Limb-Threatening Ischemia
Kentaro Inoue, Shinichiro Yoshino, Yutaka Matsubara, Tadashi Furuyama et al.
2026-10-01 · DOI: 10.5551/jat.66098The PREVENT Risk Equations and Cardiovascular Prevention in East Asia
Mitsuaki Sawano, Kentaro Ejiri, Yuichiro Mori, Hokyou Lee et al.
2026-10-01 · DOI: 10.5551/jat.rv22056Serum Lipids and Glaucoma
Atsuya Miki
2026-10-01 · DOI: 10.5551/jat.ed308A Literature Review on the Waist Circumference Criteria for Metabolic Syndrome in Japan: Evidence and Implications for Cardiovascular Risk Stratification
Tomoe Uchida, Aya Hirata
2026-09-01 · DOI: 10.5551/jat.errv22051It’s Time to Measure Lp(a): Recognizing a Neglected Cardiovascular Risk
Hayato Tada, Masayuki Takamura
2026-09-01 · DOI: 10.5551/jat.ed307A Phase 1 Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Zerlasiran in Japanese Participants
Henry Fok, Mariko Harada-Shiba, David Rider, Yasuko Owada et al.
2026-09-01 · DOI: 10.5551/jat.66214Cross-Sectional Association of Lipoprotein(a) Levels With Vascular Complications and Related Parameters in a Japanese Type 2 Diabetes Cohort
Tsutomu Hirano, Mayumi Uetani, Kento Nakata, Natsuko Suzuki et al.
2026-09-01 · DOI: 10.5551/jat.66152Major Bleeding During Factor Xa Inhibitor Therapy: Lessons from the Pre-Andexanet Era in Japan
Manabu Minami
2026-09-01 · DOI: 10.5551/jat.ed312Association Between Plasma Omega-3 and Omega-6 Fatty Acid Levels and Atrial Fibrillation: A Large-Scale, Real-World Retrospective Study in Japan
Naotake Yanagisawa, Kazutoshi Fujibayashi, Tetsuro Miyazaki, Hiroyuki Daida et al.
2026-09-01 · DOI: 10.5551/jat.66117Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from <i>RNF213</i>
Shuhei Okazaki
2026-09-01 · DOI: 10.5551/jat.rv22053Current and Future Perspectives of LDL-C Lowering Therapies 2026
Hayato Tada, Kenji Sakata, Soichiro Usui, Masayuki Takamura et al.
2026-09-01 · DOI: 10.5551/jat.rv22052Polyunsaturated Fatty Acids and Atrial Fibrillation: Friend or Foe?
Takeo Sato
2026-09-01 · DOI: 10.5551/jat.ed310A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate
Tomoko Otsuki, Yumi Chung, Yusuke Kawachi, Shiho Komuku et al.
2026-09-01 · DOI: 10.5551/jat.66218Hospital Course and Outcomes After Major Bleeding in Patients on Factor Xa Inhibitors in Japan: A Nationwide Observational Study
Shun Kohsaka, Masahiro Yasaka, Mitsuru Hoshino, Ryotaro Ide et al.
2026-09-01 · DOI: 10.5551/jat.65869Reviews
Community Reviews
Version History
October 9, 2026 at 8:34 pm
October 2, 2026